BIOGRAPHY
Youn H. Kim, M.D. is the Joanne and Peter Haas Jr. Professor for Cutaneous Lymphoma Research at Stanford University School of Medicine and the Stanford Cancer institute. Dr. Kim is the Director of the Multidisciplinary Cutaneous Lymphoma Clinic and Research Program. Dr. Kim is a member of the T-cell Lymphoma/Cutaneous Lymphoma Panel of the National Comprehensive Cancer Network (NCCN). She serves on the Board of Directors of the International Society for Cutaneous Lymphomas (ISCL), the US Cutaneous Lymphoma Consortium (USCLC), and the Cutaneous Lymphoma Foundation (CLF) and has served as the President of ISCL. Dr. Kim is the co-founder and global co-leader of the Cutaneous Lymphoma International Consortium (CLIC) and spearheaded the establishment of the first CL international prognostic index, CLIPI, in advanced mycosis fungoides (MF) and Sézary syndrome (SS).
SESSIONS
DISCLOSURES
CRISPR Therapeutics – Investigator(Grants/Research Funding); Dren Bio, Inc – Investigator(Grants/Research Funding), Other(No Compensation Received); Innate Pharma S.A. – Other(No Compensation Received); Innate Pharma, S.A. – Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LIBO Pharma Corp. – Advisory Board(Honoraria); ONO-Pharma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Secura Bio – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Speaker(Honoraria); Treeline – Investigator(Grants/Research Funding);